Cargando…

Biological Basis for Cerebral Dysfunction in Schizophrenia in Contrast with Alzheimer’s Disease

Schizophrenia and Alzheimer’s disease are two disorders that, while conceptualized as pathophysiologically and clinically distinct, cause substantial cognitive and behavioral impairment worldwide, and target apparently similar – or nearby – circuitry in regions such as the temporal and frontal lobes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuljiš, Rodrigo O., Colom, Luis V., Rojo, Leonel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3909944/ https://www.ncbi.nlm.nih.gov/pubmed/24550846 http://dx.doi.org/10.3389/fpsyt.2013.00119

Ejemplares similares

Is Inner Speech the Basis of Auditory Verbal Hallucination in Schizophrenia?
por: Cho, Raymond, et al.
Publicado: (2014)

The Fourth Element Targeting Hypothesis of Alzheimer's Disease Pathogenesis and Pathophysiology
por: Kuljiš, Rodrigo O.
Publicado: (2010)

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

Altered Cerebral Blood Flow in Alzheimer's Disease With Depression
por: Li, Runzhi, et al.
Publicado: (2021)

Integrative Understanding of Emergent Brain Properties, Quantum Brain Hypotheses, and Connectome Alterations in Dementia are Key Challenges to Conquer Alzheimer's Disease
por: Kuljiš, Rodrigo O.
Publicado: (2010)

Can Neurostimulation Prevent the Risk of Alzheimer's Disease in Elderly Individuals with Schizophrenia?
por: Sfera, Adonis
Publicado: (2013)

A Possible Common Neurophysiologic Basis for MDD, Bipolar Disorder, and Schizophrenia: Lessons from Electrophysiology
por: Shahaf, Goded
Publicado: (2016)

Editorial: Biological Basis and Therapeutics of Behavioral and Psychological Symptoms of Dementia
por: Davalos, Deana, et al.
Publicado: (2022)

Novel Treatment Strategies Targeting Myelin and Oligodendrocyte Dysfunction in Schizophrenia
por: Gouvêa-Junqueira, Danielle, et al.
Publicado: (2020)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Metaphor Processing Dysfunctions in Schizophrenia Patients With and Without Substance Use Disorders
por: Karabanowicz, Ewa, et al.
Publicado: (2020)

Cariprazine's Potential in Improving Social Dysfunction in Patients With Schizophrenia: A Perspective
por: Morozov, Petr, et al.
Publicado: (2022)

Core of sensory gating deficits in first-episode schizophrenia: attention dysfunction
por: Ding, Yushen, et al.
Publicado: (2023)

Differentiation of the retinal morphology aging trajectories in schizophrenia and their associations with cognitive dysfunctions
por: Domagała, Adam, et al.
Publicado: (2023)

Regional Cerebral Associations Between Psychometric Tests and Imaging Biomarkers in Alzheimer’s Disease
por: Hedderich, Dennis M., et al.
Publicado: (2020)

The Effects of Acupuncture on Glutamatergic Neurotransmission in Depression, Anxiety, Schizophrenia, and Alzheimer's Disease: A Review of the Literature
por: Tu, Cheng-Hao, et al.
Publicado: (2019)

Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia
por: Morozova, Anna, et al.
Publicado: (2021)

Abnormal Spontaneous Gamma Power Is Associated With Verbal Learning and Memory Dysfunction in Schizophrenia
por: Tanaka-Koshiyama, Kumiko, et al.
Publicado: (2020)

Case Report: Cariprazine in a Patient With Schizophrenia, Substance Abuse, and Cognitive Dysfunction
por: Rodriguez Cruz, Jose, et al.
Publicado: (2021)

Case Report: Usefulness of Biomarkers for Alzheimer's Disease in Two Cases With Very-Late-Onset Schizophrenia-Like Psychosis
por: Satake, Yuto, et al.
Publicado: (2021)

Cerebellar-Motor Dysfunction in Schizophrenia and Psychosis-Risk: The Importance of Regional Cerebellar Analysis Approaches
por: Bernard, Jessica A., et al.
Publicado: (2014)

Connectivity, Pharmacology, and Computation: Toward a Mechanistic Understanding of Neural System Dysfunction in Schizophrenia
por: Anticevic, Alan, et al.
Publicado: (2013)

Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Exercise-Induced Cognitive Plasticity, Implications for Mild Cognitive Impairment and Alzheimer’s Disease
por: Foster, Philip P., et al.
Publicado: (2011)

Similar and Different Gray Matter Deficits in Schizophrenia Patients and Their Unaffected Biological Relatives
por: Xiao, Yuan, et al.
Publicado: (2013)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

Suicide Attempts, Neurocognitive Dysfunctions and Clinical Correlates in Middle-Aged and Elderly Chinese Schizophrenia Patients
por: Huang, Yuanyuan, et al.
Publicado: (2021)

Inefficient Preparatory fMRI-BOLD Network Activations Predict Working Memory Dysfunctions in Patients with Schizophrenia
por: Baenninger, Anja, et al.
Publicado: (2016)

The Relationship Between Cognitive Dysfunction and Symptom Dimensions Across Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Zhu, Yue, et al.
Publicado: (2019)

Bilingualism as a Contributor to Cognitive Reserve? Evidence from Cerebral Glucose Metabolism in Mild Cognitive Impairment and Alzheimer’s Disease
por: Kowoll, Magdalena Eva, et al.
Publicado: (2016)

Corrigendum: Inefficient Preparatory fMRI-BOLD Network Activations Predict Working Memory Dysfunctions in Patients with Schizophrenia
por: Baenninger, Anja, et al.
Publicado: (2016)

Attitudes of Italian Psychiatrists Toward the Evaluation of Physical Comorbidities and Sexual Dysfunction in Patients With Schizophrenia. Implications for Clinical Practice
por: Monteleone, Palmiero, et al.
Publicado: (2019)

Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis
por: Dombi, Zsófia B., et al.
Publicado: (2022)

Cognitive dysfunction and cortical structural abnormalities in first-episode drug-naïve schizophrenia patients with auditory verbal hallucination
por: Shen, Xuran, et al.
Publicado: (2022)

Eye dominance and minor physical anomalies in schizophrenia: relations between two biological markers of abnormal neurodevelopment
por: Akabalieva, Katerina
Publicado: (2023)

Putative Astroglial Dysfunction in Schizophrenia: A Meta-Analysis of (1)H-MRS Studies of Medial Prefrontal Myo-Inositol
por: Das, Tushar Kanti, et al.
Publicado: (2018)

Enhanced Prefrontal Regional Homogeneity and Its Correlations With Cognitive Dysfunction/Psychopathology in Patients With First-Diagnosed and Drug-Naive Schizophrenia
por: Gao, Shuzhan, et al.
Publicado: (2020)

Sexual Dysfunction in Chronically Medicated Male Inpatients With Schizophrenia: Prevalence, Risk Factors, Clinical Manifestations, and Response to Sexual Arousal
por: Liu, Dianying, et al.
Publicado: (2022)

Disease Severity in Treatment Resistant Schizophrenia Patients Is Mainly Affected by Negative Symptoms, Which Mediate the Effects of Cognitive Dysfunctions and Neurological Soft Signs
por: Iasevoli, Felice, et al.
Publicado: (2018)

Evidence for Schizophrenia-Specific Pathophysiology of Nicotine Dependence
por: Ward, Heather Burrell, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8oq4u2mopqjj5qec0cphr6jm2k